tiprankstipranks
Trending News
More News >
Omniab, Inc. (OABI)
:OABI
US Market
Advertisement

OmniAb (OABI) Similar Stocks

Compare
198 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
OmniAb
$1.95
$249.56M
-50.61%
7 Buy
0 Hold
0 Sell
Strong Buy
Verastem
$5.97
$334.09M
155.13%
9 Buy
0 Hold
0 Sell
Strong Buy
Xoma
$28.44
$340.34M
21.38%
2 Buy
1 Hold
0 Sell
Moderate Buy
Compass Therapeutics
$2.93
$407.93M
205.21%
6 Buy
0 Hold
0 Sell
Strong Buy
Humacyte
$2.26
$353.67M
-72.17%
3 Buy
0 Hold
0 Sell
Strong Buy
Candel Therapeutics
$6.31
$329.01M
18.20%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OABI
OmniAb
2.04
-2.02
-49.75%
VSTM
Verastem
5.97
3.75
168.92%
XOMA
Xoma
28.44
5.34
23.12%
CMPX
Compass Therapeutics
2.93
2.03
225.56%
HUMA
Humacyte
2.31
-5.52
-70.50%
CADL
Candel Therapeutics
6.17
1.15
22.91%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis